한국국제의료협회 Korea International Medical Association, KHIDI, Osong Life Science Complex, #643, Yonje-ri, Kangwoe-myon (2026)

21/11/2025

Seoul St. Mary’s Hospital Signs MOU with Oman Armed Forces Hospital… Expanding Global Medical Cooperation

Seoul St. Mary’s Hospital is strengthening global cooperation to expand K-medical throughout the Middle East region.

The hospital announced on the 7th that it signed a Memorandum of Understanding (MOU) on October 28 with the Oman Armed Forces Hospital (MCMSS) to enhance medical collaboration.

Through this partnership, Seoul St. Mary’s Hospital aims to establish a sustainable international cooperation system across clinical care, research, and education, while promoting patient-centered K-medical globally. Based on more than a year of mutual exchange and trust since 2024, the two institutions plan to expand collaboration to include:

Establishment of a patient referral system

Operation of medical staff training and education programs

Joint research and academic cooperation

With the signing of this MOU, patients supported by the Omani government will now be able to receive treatment at Seoul St. Mary’s Hospital. Additionally, through medical staff training visits, the hospital will transfer advanced medical technologies and clinical expertise—including robotic surgery—to Oman. Collaboration will focus on complex and high-risk areas such as hematologic cancers, solid tumors, and cardiovascular and cerebrovascular diseases, enabling Seoul St. Mary’s Hospital to extend the core DNA of K-medical into the Middle East.

The signing ceremony was attended by key officials from both institutions, including Seoul St. Mary’s Hospital President Lee Ji-yeol, Vice President for External Affairs Yang Dong-won, Oman Armed Forces Hospital Director Saleh Al Abri, Oman’s Ambassador to Korea Zakariya Al Saadi, and Deputy Ambassador Lim Al Siyabi.

President Lee stated,
“Seoul St. Mary’s Hospital is leading Asia in advanced medical technologies such as robotic surgery, drawing patients and medical professionals from around the world, including the Middle East. Through this agreement, we hope to build various forms of medical cooperation grounded in mutual trust.”

Director Saleh Al Abri of the Oman Armed Forces Hospital said,
“We expect that Seoul St. Mary’s Hospital’s advanced medical systems and technologies will significantly enhance the clinical and educational capabilities of our hospital. We hope this agreement will further invigorate medical exchanges between Oman and the Republic of Korea.”

Since President Lee presented his vision of “LINK—Leadership and Innovation for the Next era of K-Medical” upon taking office, the hospital plans to continue expanding international cooperation in the coming years.

21/11/2025

Sejong Hospital Designated as a “2025 Excellent Medical Tourism Institution”

Granted Authority to Apply for Electronic Visas for Inviting Foreign Patients

[Medical News / Daily Boseo = Reporter Lee Sang-man]
HyeWon Medical Foundation’s Sejong Hospital (Chairman Park Jin-sik) announced on the 28th that it has been designated by the Ministry of Justice as a “2025 Excellent Medical Tourism Institution.”

(Photo: Sejong Hospital’s Foreign Patient Coordinators)

The “Excellent Medical Tourism Institution” designation, established under the Act on Support for Overseas Expansion of Medical Institutions and Attraction of Foreign Patients, is awarded by the Ministry of Justice—the government authority overseeing immigration affairs—following an evaluation of medical institutions’ performance in attracting and treating foreign patients, as well as their visa approval rates.

As a result of this designation, Bucheon Sejong Hospital and Incheon Sejong Hospital have been granted the authority to invite foreign nationals by applying for electronic visas (e-visas) through the Korea Visa Portal.

Foreign patients using these hospitals can now skip submitting financial proof documents when applying for e-visas, and the range of accompanying caregivers and family members has been expanded to include collateral relatives up to the fourth degree, providing greater convenience during immigration procedures.

Sejong Hospital, which operates the nation’s only heart-specialized hospital, has achieved the “Triple Crown” of medical certifications—including accreditation from the Joint Commission International (JCI), the domestic hospital accreditation for acute care facilities, and the Korea Accreditation Program for Hospitals Serving Foreign Patients (KAHF).

Chairman Park Jin-sik stated,“With this designation as an Excellent Medical Tourism Institution, the convenience for foreign patients visiting Sejong Hospital has been greatly improved. We will continue to provide customized and world-class medical services for both domestic and international patients.”

21/11/2025

Seoul Asan Hospital Signs Agreement with Japan’s QST on Carbon Ion Therapy — Aiming for Operation by 2031

(Seoul = News1) Reporter Kim Gyubin — Seoul Asan Hospital has signed an agreement with Japan’s QST (National Institutes for Quantum Science and Technology) Hospital to cooperate in education and clinical research related to carbon ion therapy.

Seoul Asan Hospital announced on the 29th that it had signed a memorandum of understanding (MOU) on carbon ion therapy with QST Hospital in Chiba Prefecture, Japan, on the 27th (local time). The signing ceremony was attended by Song Si-yeol, head of the Carbon Ion Therapy Project (and director of the Cancer Hospital) at Asan Medical Center, and Hitoshi Ishikawa, director of QST Hospital, along with officials from both institutions.

QST Hospital is the world’s first medical institution to begin carbon ion therapy, starting in 1994. Under this agreement, the two organizations will collaborate in areas such as professional training, patient exchange, and clinical research in carbon ion therapy.

In April, Seoul Asan Hospital signed a contract with the Toshiba ESS–DK Medical Solutions consortium and is pursuing a project to begin operation of its carbon ion therapy system by 2031.

The carbon ion therapy facility will be built on the Asan Hospital campus in Pungnap-dong, Songpa-gu, Seoul, with a total floor area of 40,880 square meters (about 12,388 pyeong). According to the hospital, it will be the largest facility of its kind in Korea, equipped with two rotating gantry treatment systems and one fixed-beam treatment system. It will also incorporate a CT-based image-guided system to monitor real-time changes in tumor size and position, allowing for precise, personalized treatment.

The carbon ion therapy system will be used to treat prostate, pancreatic, and liver cancers, as well as lung cancer, sarcomas, and recurrent cancers that show resistance to conventional treatments. In addition to carbon ions, other particles such as helium, neon, and oxygen ions can be used to minimize damage to healthy tissues while effectively targeting resistant tumors.

Song Si-yeol, head of the Carbon Ion Therapy Project at Asan Medical Center, stated, “The experience of QST Hospital, which was the first in the world to introduce carbon ion therapy in clinical practice, will be of great help to Asan Hospital. We will continue to expand treatment opportunities for patients with intractable cancers and strive to create a patient-centered treatment environment.”

rnkim@news1.kr

21/11/2025

Jaseng Hospital of Korean Medicine Expands International Exchanges with Major U.S. Medical Schools

"We will strive to lead the globalization of Korean medicine"

Jaseng Hospital of Korean Medicine announced on the 20th that it visited Indiana University School of Medicine and the University of Virginia School of Integrative Medicine in the U.S. to conduct Korean medicine education programs and explore ways to strengthen international cooperation.

Medical staff from Jaseng Hospital delivered lectures at the University of Virginia School of Integrative Medicine on September 27.

This program was promoted as part of the “Korean Medicine Overseas Export and Foreign Patient Attraction Support Project” by the Ministry of Health and Welfare and the Korea Promotion Institute for Traditional Medicine.
Participants included Yoon Young-seok, Director of Jaseng Medical Academy, and other key medical staff and officials. They met with professors and researchers from the universities to discuss plans for international collaboration and toured medical and research facilities. They also provided local medical professionals and students with lectures and training on Korean medicine treatments for musculoskeletal disorders, clinical cases, and educational systems.

Discussions were also held on the co-hosting of the 6th Jaseng International Academic Conference scheduled for next August. Jaseng Hospital has been organizing this academic conference to promote scientific evidence for Korean medicine and enhance its potential role in the future of integrative medicine.

At the University of Virginia School of Integrative Medicine, lectures and hands-on sessions were held on Jaseng’s unique non-surgical spine and joint treatment methods, including Motion Style Acupuncture Treatment (MSAT).

Director Yoon said, “This international exchange was a meaningful opportunity to promote the excellence of Korean medicine and strengthen cooperation with overseas medical professionals. We will continue to expand our global network and take the lead in globalizing Korean medicine.”

Meanwhile, Jaseng Hospital continues its multifaceted efforts for the globalization of Korean medicine through international clinical training programs and internships for foreign medical staff. In July, it became the only East Asian medical institution to receive reaccreditation from the Accreditation Council for Continuing Medical Education (ACCME) in the U.S. Earlier this year, it was also the only Asian medical institution invited to present its research achievements at the Academic Consortium for Integrative Medicine and Health (ACIMH) held in Seattle.

21/11/2025

Newsweek Announces World’s Best Specialized Hospitals 2026: Ten KIMA Member Hospitals Recognized

On September 10 (local time), U.S. current affairs weekly Newsweek released its World’s Best Specialized Hospitals 2026 rankings, with ten member institutions of the Korea International Medical Association (KIMA) earning places on the list. This achievement once again underscores the global standing of Korean healthcare.

Conducted in collaboration with global data research firm Statista, the annual ranking highlights leading hospitals worldwide across 12 medical fields. The specialties assessed include cardiac surgery, cardiology, endocrinology, gastroenterology, neurology, neurosurgery, oncology, orthopedics, pediatrics, pulmonology, urology, and obstetrics & gynecology.

In particular, Korea demonstrated remarkable strength in oncology: three Korean hospitals were ranked among the global top 10 in this category, second only to the United States (four hospitals). France, the United Kingdom, and Canada each had one institution listed.

The evaluation is based on three pillars of data:

1. International online survey of medical experts

2. Accreditation data

3. PROMs (Patient-Reported Outcome Measures) Implementation Survey

The scope of the rankings includes: the top 300 hospitals in cardiology and oncology; the top 250 in pediatrics; the top 150 in cardiac surgery, endocrinology, gastroenterology, pulmonology, and orthopedics; and the top 125 in neurosurgery and urology. This year, the number of ranked hospitals in neurology and obstetrics & gynecology was expanded to 150 and 125, respectively.

The following KIMA member hospitals were included in the World’s Best Specialized Hospitals 2026, listed in alphabetical order:

· Asan Medical Center

· Ewha Womans University – Seoul Hospital

· Severance Hospital – Yonsei University

· Hanyang University – Seoul Hospital

· Korea University – Anam Hospital

· National Cancer Center

· Samsung Medical Center

· Seoul National University – Bundang Hospital

· Seoul National University Hospital

· The Catholic University of Korea – Seoul St. Mary’s Hospital

A KIMA representative stated, “This recognition highlights the outstanding expertise and international competitiveness of our member hospitals. KIMA will continue to work with its members to further promote the excellence of Korean healthcare worldwide.”

21/11/2025

National Cancer Center Opens Sarcoma Center “Providing Optimal Personalized Treatment

The National Cancer Center announced on the 11th that it held an opening ceremony for its new Sarcoma Center on September 9, with the aim of delivering optimal, personalized treatment to patients with sarcoma, one of the representative rare cancers.

Sarcoma is a rare cancer that occurs in both children and adults, requiring multidisciplinary collaboration throughout the diagnosis and treatment process.

Since 2017, medical staff at the National Cancer Center have organized a “Sarcoma Research Group” to conduct both clinical and basic research. In 2018, they launched a multidisciplinary sarcoma care program, providing tailored treatment for patients.

In particular, the center has been laying the foundation for precision medicine for sarcoma patients through:

Multicenter clinical trials, including Phase I and II trials for recurrent and advanced osteosarcoma, and a Phase II trial of adjuvant chemotherapy for stage III soft tissue sarcoma;

Korea’s first study on skeletal reconstruction using 3D printing;

Establishment of a multicenter sarcoma resource-sharing platform, leading to the nation’s first development of a sarcoma-specific cancer gene panel and new drug research as part of next-generation biotechnology initiatives.

Building on these achievements, the Sarcoma Center plans to assign approximately 30 sarcoma patients per day to a dedicated team. Specialists from orthopedic oncology (musculoskeletal tumor clinic), hematology-oncology, pediatrics, radiation oncology, pathology, and radiology will collaborate under the Rare Cancer Center. In addition, the sharing of inpatient care staff, on-call physicians, and physician assistants is expected to enhance hospital efficiency.

Yang Han-Kwang, President of the National Cancer Center, stated, “With the launch of the Sarcoma Center, we expect to further invigorate our clinical and translational research in sarcoma and provide the best possible treatment. The Rare Cancer Center, which encompasses the Sarcoma Center, will be elevated to the Rare Cancer Division, allowing the National Cancer Center to fully uphold its public mission.”

Kim Joon-Hyuk, Director of the Rare Cancer Center, added, “In Korea, approximately 2,000 new sarcoma cases are diagnosed each year, and the number is steadily rising. Through integrated treatment and research involving multiple departments within the Sarcoma Center, we will strive to improve treatment outcomes for sarcoma patients and set an exemplary standard in the field of rare cancers.”

21/11/2025

Ewha Womans University Medical Center Conducts 12th Medical Volunteer Mission in Mongolia

Ewha Womans University Medical Center (President Kyung-Ha Yoo) recently carried out its 12th medical volunteer service in Mongolia.

The Ewha Mongolia Medical Volunteer Team included Kang Kyung-Ho (Head of the International Healthcare Center, Department of Surgery, Ewha Womans University Seoul Hospital), Lee Hee-Sung (Deputy Head, Department of Surgery, Ewha Womans University Mokdong Hospital), Yoon Hana (Urology, Ewha Womans University Seoul Hospital), Park Jang-Won (Orthopedic Surgery, Ewha Womans University Seoul Hospital), Kim Yoon-Hwan (Obstetrics and Gynecology, Ewha Womans University Mokdong Hospital), along with nurses and administrative staff. In total, 14 members from Ewha Medical Center and 16 local Mongolian medical professionals participated.

Ewha’s connection with Mongolia began in 2011, when the volunteer team was invited by then First Lady Bolormaa to provide community-based medical services. Except for the period affected by COVID-19 from 2020 to 2022, Ewha has dispatched medical volunteer teams to Mongolia every year since then. This year, the medical team visited two regions—Bayangol in Ulaanbaatar and Bayan-Ölgii in western Mongolia—where they treated a total of 2,036 patients.

Kang Kyung-Ho, Head of the International Healthcare Center, said, “I feel deeply gratified that we have been able to continue meaningful activities in Mongolia for 15 years. Mongolians call our country ‘Solongos,’ meaning ‘the Land of the Rainbow,’ and regard Korea as a brother nation. Through this overseas medical volunteer mission, we were able to fully experience brotherhood and humanity.” He added, “Ewha Medical Center will continue to uphold its founding spirit of ‘service and sharing,’ promote its advanced medical capabilities to the world, and make greater efforts to attract international patients.”

Source: The Medical News (http://www.bosa.co.kr)

21/11/2025

Incheon Sejong Hospital’s General Surgery Center Chief, Dr. Sang-Myung Lee, Records 3,600 Cases of Benign Disease Surgeries as a Sole Surgeon

Dr. Sang-Myung Lee, Chief of the General Surgery Center at Incheon Sejong Hospital, has achieved a milestone of 3,600 surgeries for benign diseases as a single operating surgeon.

The breakdown of procedures includes:

1,692 cholecystectomies (gallbladder removal)

669 hernia repairs

1,244 appendectomies

In addition to conventional single-incision laparoscopic surgery, Dr. Lee has been actively utilizing the da Vinci SP single-port robotic surgery system, which Incheon Sejong Hospital became the first general hospital in the Gyeongin region to introduce in 2023.

In its first year of adoption, he also became the first in the Incheon region to successfully perform totally extraperitoneal repair (TEP) using the da Vinci SP, thereby contributing to the wider adoption of robotic surgery in Korea.

The TEP technique involves inserting the laparoscope between the peritoneum and the posterior abdominal wall without entering the peritoneal cavity. Gas is infused to create a surgical space, allowing access to the hernia site. While this approach eliminates the risk of intra-abdominal injury, it requires a high level of surgical expertise due to the limited working space.

Last year, a surgical specialist from Nagoya Ekisaikai Hospital in Japan visited Incheon Sejong Hospital to observe Dr. Lee’s da Vinci SP robotic hernia surgery firsthand, underscoring his role as a focal point for global collaboration in surgical innovation.

Dr. Lee stated, “Surpassing 3,600 benign disease surgeries using single-incision laparoscopic and da Vinci SP single-port robotic surgery systems is not only a personal achievement but also the result of organic team collaboration, standardized surgical techniques, and systematic patient management. Moving forward, we remain committed to providing advanced medical services that enhance patients’ quality of life, including the treatment of critical and emergency conditions.”

21/11/2025

KHIDI and Abu Dhabi Department of Health Discuss Cooperation to Expand UAE Government-Sponsored Patient Program

Over a three-day period from August 4 to 6, a delegation from the International Patient Care Center (IPCC) under the Abu Dhabi Department of Health (DOH) in the United Arab Emirates (UAE) paid an official visit to Korea to tour major domestic medical institutions and discuss ways to strengthen Korea–UAE healthcare cooperation, the Korea Health Industry Development Institute (KHIDI) announced on the 7th.

This marks the first visit by UAE health authorities to Korea in three years since 2022. The four-member delegation, led by Kholood Al Dhalai, Director of the DOH IPCC, visited five contracted institutions: Asan Medical Center, Samsung Medical Center, Seoul St. Mary’s Hospital, Seoul National University Hospital, and Severance Hospital.

During their visits, the delegation gathered feedback from UAE patients receiving treatment in Korea, including satisfaction levels and challenges faced. They reviewed in detail not only patient safety–focused medical service quality, but also non-medical support such as Arabic interpretation, provision of halal meals, operation of prayer rooms, and transportation services. They also analyzed how these services differ from those offered in other UAE patient referral destinations, including the United States, Germany, and Türkiye.

On August 6, the delegation met with the Ministry of Health and Welfare and KHIDI to exchange views on strengthening bilateral healthcare cooperation. Key topics included expanding the UAE government-sponsored patient program, sharing information on Korea’s latest medical technology trends, and revitalizing the Visiting Physician Program (VPP) for Korean medical professionals in the UAE.

The DOH IPCC expressed interest in expanding patient assignment (PA) agreements with Korean medical institutions. Both sides also agreed to hold regular working-level meetings to develop concrete cooperation measures.

Director Kholood Al Dhalai stated, “This visit allowed us to witness Korea’s advanced medical environment firsthand. We look forward not only to expanding the government-sponsored patient program but also to working closely with Korean medical professionals.”

Han Dong-woo, Director General of the International Medical Division at KHIDI, commented, “We hope this visit will serve as a catalyst for expanding the inflow of UAE government-sponsored patients, as well as achieving tangible cooperation outcomes with the UAE in areas such as medical professional training and the promotion of telemedicine.”

21/11/2025

[Seoul National University Hospital] “Can dementia be tackled with a 15-second injection?” – Why the world is paying attention

New technologies to eliminate causes of dementia… K-Bio rises to the challenge

World’s Largest Alzheimer’s Conference
An oral drug for dementia by AriBio
Dong-A ST’s preclinical candidate “Effective in removing tau protein”
Self-injection treatments, blood diagnostics, and more
Global pharmaceutical companies unveil new technologies

A 15-second at-home injection of an antibody treatment for Alzheimer’s, and blood tests that diagnose Alzheimer’s with precision— These innovations were unveiled at the Alzheimer’s Association International Conference (AAIC 2025), held from July 27 to 31 in Toronto, Canada. As the world’s largest Alzheimer’s research event, AAIC 2025 introduced a range of strategies for overcoming intractable brain diseases. Korean companies also entered the fray to seize a share of the nearly 9 trillion won Alzheimer’s drug market.

▷ Korean medical expert gives keynote address
On July 30, Professor Inhee Mook of Seoul National University College of Medicine delivered a keynote speech at the AAIC 2025 main hall. She presented a new hypothesis that substances in the gut can reach the brain through the vagus nerve, a direct link between the two organs. Previous research mostly focused on the bloodstream as the connecting pathway, but failed to explain how substances crossed the blood-brain barrier (BBB). Professor Mook argued that “visceral sensory nerves directly connect the gut and brain, and may act as a new pathway for toxic substances in the gut to reach the brain.” Korean researchers thus introduced a new agenda to the global medical community.

More than 10,000 experts from over 100 countries participated in AAIC 2025. Korean pharmaceutical and biotech companies also showcased their capabilities. AriBio presented four research results on its Phase 3 clinical candidate ‘AR1001’ via posters. It demonstrated that standalone administration of AR1001 over 26 weeks improved cognitive function and reduced tau protein levels in Alzheimer’s patients. Fred Kim, head of AriBio’s U.S. operations, stated, “We confirmed high global academic interest in AR1001 ahead of our Phase 3 topline data release scheduled for early next year.”

Dong-A ST unveiled preclinical results of its tau aggregation inhibitor ‘DA-7503,’ which is currently in Phase 1 trials in Korea. Initial data will be released in Q4 this year. Companies like ABL Bio and Illimis Therapeutics also made presentations. On July 28, ABL Bio shared animal study results of its “Grabody-B” technology that effectively delivers drugs across the BBB. Illimis Therapeutics introduced research showing that its dual-target fusion protein can prevent beta-amyloid accumulation. Other companies like Amyloid Solution, VUNO, Neurophet, and PeopleBio unveiled new diagnostic technologies.

▷ Blood-based diagnostics, preventive vaccines
Global giants are also focused on transforming dementia treatment and diagnosis. On July 30, Biogen (U.S.) and Eisai (Japan) revealed results of switching their intravenous Alzheimer’s antibody drug “Leqembi” to a subcutaneous injection suitable for home use. The U.S. FDA is set to decide on its approval by August 31. Swiss pharmaceutical company Roche introduced “Elecsys pTau217,” a blood test alternative to PET-CT scans. Currently, it takes an average of 2.8 years for patients to receive a definitive Alzheimer’s diagnosis due to the complexity and cost of cognitive testing. Blood tests are expected to overcome these limitations.

British firm GlaxoSmithKline (GSK) presented findings that shingles vaccination may reduce the risk of dementia by 32% to 51%.

21/11/2025

Korea University Anam Hospital Department of Urology Celebrates 3,000 Robotic Surgeries

On July 24, the Department of Urology at Korea University Anam Hospital held a ceremony to commemorate reaching 3,000 robotic surgeries. The department achieved this milestone on July 17, becoming the first single department at Korea University Anam Hospital to reach this number.

Since performing its first robotic surgery on July 5, 2007, the Department of Urology marked 1,000 cases in 2019, 2,000 cases in 2023, and has now reached 3,000 cases in 2025.

Professor Seokho Kang has led the standardization of robotic surgery for bladder cancer in Asia, being the first in the region to successfully perform and record the highest number of “robotic radical cystectomy with total intracorporeal urinary diversion.” He established a system that enables the entire complex bladder cancer surgery to be conducted solely using robotic techniques, significantly improving surgical precision. His outcomes have shown excellent results in terms of functional preservation and reduced complications.

Professor Kang is also recognized internationally for advancing robotic techniques for prostate cancer surgeries and serves as an honorary professor at the Global Robotics Institute (GRI) at AdventHealth, University of Central Florida—one of the world's most prestigious institutions for robotic surgery education. Recently, he has also been leading live international telesurgery sessions to train global medical professionals in robotic procedures.

Professor Jisung Shim successfully performed Korea’s first robotic artificial urinary sphincter implantation for female incontinence patients, expanding the field of female urological reconstruction. Professor Mingu Park applied an AI-powered autonomous endoscopic robot for kidney stone treatment, while Professors Taeil Roh and Seongku Yun have also performed complex robotic surgeries for bladder and prostate cancer.

21/11/2025

From Emergency Response to Wellness Travel: Halla Medical Foundation Signs MOU with Air Seoul

On July 17, Halla Medical Foundation announced that it had signed a memorandum of understanding (MOU) with Air Seoul at Jeju Halla Hospital to collaborate on joint marketing efforts and medical service partnerships.

Through this agreement, the two parties will cooperate to enhance passenger safety and establish an effective emergency response system for Air Seoul travelers.

Halla Medical Foundation will provide prompt medical support in the event of in-flight medical emergencies involving Air Seoul passengers. The two organizations also plan to engage in a wide range of initiatives—including social contribution activities and co-marketing campaigns—aimed at promoting the safety and health of travelers.

A representative from Halla Medical Foundation stated, “This agreement will help create a safer travel environment for passengers, while also contributing to the popularization of wellness travel through THE WE, Korea’s only premium health resort.”

Meanwhile, THE WE—a health resort operated by Halla Medical Foundation that integrates ‘WE Hospital’ and the five-star ‘WE Hotel’—is currently running a joint wellness travel promotion with Air Seoul, titled “Take a Break; Book a Ticket.”

Source: Jeju Sori (https://www.jejusori.net)

Monday	09:00 - 18:00
Tuesday	09:00 - 18:00
Wednesday	09:00 - 18:00
Thursday	09:00 - 18:00
Friday	09:00 - 18:00

한국국제의료협회 Korea International Medical Association

21/11/2025

21/11/2025

21/11/2025

21/11/2025

21/11/2025

21/11/2025

21/11/2025

21/11/2025

21/11/2025

21/11/2025

21/11/2025

21/11/2025

Address

Opening Hours

Telephone

Website

Alerts

Contact The Practice

Shortcuts

Share